Hyderabad, November 11, 2025: Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India’s fastest-growing Contract Research, Development & Manufacturing Organizations (CRDMO), has announced plans to recruit 200 scientists in November 2025 to meet the rising demand for its Discovery and Chemistry, Manufacturing & Controls (CMC) services.
The company will hold walk-in interviews in Bengaluru on November 15–16, 2025, at Sai Vishram Business Hotel, Hebbagodi, from 9:00 a.m. to 5:00 p.m.
The open positions span various scientific functions, including Process R&D, Analytical R&D, Process Engineering, Biology (in vitro and in vivo), and DMPK. Eligible candidates include those with M.Sc. (Organic Chemistry, Life Sciences, Microbiology, Biochemistry, Biotechnology), M.Pharm (Pharmacology or related fields), B.E./M.E. (Chemical Engineering), or Ph.D. qualifications, along with 2–14 years of experience.
Siva Chittor, Whole-Time Director and CFO of Sai Life Sciences, said,
“The current onboarding of scientists will support our expanding operations. At Sai, we are continuously building an ecosystem where scientists can do the best work of their careers — solving complex scientific challenges that make a real difference to patients’ lives.”
The company recently announced the groundbreaking of a new CMC Process R&D Center at its integrated R&D campus in Hyderabad, set for completion by September 2026. This facility will double its Process R&D capacity and add new capabilities in peptide development, oligo intermediates, linkers, formulation development, and early-phase clinical supplies.
Sai Life Sciences currently employs over 3,400 professionals and partners with more than 300 global innovators, including 18 of the top 20 pharmaceutical companies, accelerating the discovery, development, and commercialization of complex small molecules.
